Aravive Analyst Ratings
Aravive Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 08/03/2023 | — | BTIG | Downgrades | Buy → Neutral | |
| 07/21/2023 | 1311.76% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/17/2023 | 1311.76% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/10/2023 | 1311.76% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 07/03/2023 | 1311.76% | Cantor Fitzgerald | $18 → $18 | Reiterates | Overweight → Overweight |
| 06/05/2023 | 841.18% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 06/05/2023 | 684.31% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/26/2023 | 684.31% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/26/2023 | 841.18% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/25/2023 | 684.31% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/25/2023 | 841.18% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 05/17/2023 | 1311.76% | Cantor Fitzgerald | → $18 | Reiterates | Overweight → Overweight |
| 05/11/2023 | 684.31% | EF Hutton | → $10 | Reiterates | Buy → Buy |
| 05/11/2023 | 841.18% | HC Wainwright & Co. | → $12 | Reiterates | Buy → Buy |
| 03/16/2023 | 841.18% | HC Wainwright & Co. | $7 → $12 | Maintains | Buy |
| 02/21/2023 | 449.02% | HC Wainwright & Co. | → $7 | Reiterates | → Buy |
| 02/14/2023 | 684.31% | EF Hutton | → $10 | Maintains | Buy |
| 01/05/2023 | 684.31% | EF Hutton | → $10 | Initiates Coverage On | → Buy |
| 11/14/2022 | 56.86% | Piper Sandler | $6 → $2 | Maintains | Overweight |
| 10/25/2022 | 449.02% | HC Wainwright & Co. | $26 → $7 | Maintains | Buy |
| 06/03/2022 | 1076.47% | Roth Capital | → $15 | Initiates Coverage On | → Buy |
| 03/08/2021 | 1939.22% | BTIG | → $26 | Initiates Coverage On | → Buy |
| 09/18/2020 | — | William Blair | Initiates Coverage On | → Outperform | |
| 07/23/2020 | 1939.22% | HC Wainwright & Co. | $15 → $26 | Maintains | Buy |
| 03/27/2020 | 1076.47% | HC Wainwright & Co. | $25 → $15 | Maintains | Buy |
| 12/20/2019 | 1860.78% | HC Wainwright & Co. | $31 → $25 | Maintains | Buy |
| 12/10/2019 | 2252.94% | Cantor Fitzgerald | → $30 | Initiates Coverage On | → Overweight |
| 11/20/2019 | 2331.37% | HC Wainwright & Co. | $18 → $31 | Reiterates | → Buy |
| 11/19/2019 | 2723.53% | Piper Sandler | $15 → $36 | Maintains | Overweight |
| 10/10/2019 | 1311.76% | HC Wainwright & Co. | → $18 | Initiates Coverage On | → Buy |
| 05/13/2019 | 684.31% | Piper Sandler | → $10 | Initiates Coverage On | → Overweight |
| 04/09/2019 | 998.04% | Wedbush | → $14 | Initiates Coverage On | → Outperform |
| 日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
|---|---|---|---|---|---|
| 08/03/2023 | - | BTIG | 评级下调 | 购买→中性 | |
| 07/21/2023 | 1311.76% | 康托·菲茨杰拉德 | →$18 | 重申 | 超重→超重 |
| 07/17/2023 | 1311.76% | 康托·菲茨杰拉德 | →$18 | 重申 | 超重→超重 |
| 07/10/2023 | 1311.76% | 康托·菲茨杰拉德 | →$18 | 重申 | 超重→超重 |
| 07/03/2023 | 1311.76% | 康托·菲茨杰拉德 | $18→$18 | 重申 | 超重→超重 |
| 06/05/2023 | 841.18% | HC Wainwright公司 | →$12 | 重申 | 购买→购买 |
| 06/05/2023 | 684.31% | EF Hutton | →$10 | 重申 | 购买→购买 |
| 2023年05月26日 | 684.31% | EF Hutton | →$10 | 重申 | 购买→购买 |
| 2023年05月26日 | 841.18% | HC Wainwright公司 | →$12 | 重申 | 购买→购买 |
| 2023年05月25日 | 684.31% | EF Hutton | →$10 | 重申 | 购买→购买 |
| 2023年05月25日 | 841.18% | HC Wainwright公司 | →$12 | 重申 | 购买→购买 |
| 2023年05月17日 | 1311.76% | 康托·菲茨杰拉德 | →$18 | 重申 | 超重→超重 |
| 2023年05月11日 | 684.31% | EF Hutton | →$10 | 重申 | 购买→购买 |
| 2023年05月11日 | 841.18% | HC Wainwright公司 | →$12 | 重申 | 购买→购买 |
| 03/16/2023 | 841.18% | HC Wainwright公司 | $7→$12 | 维护 | 买 |
| 02/21/2023 | 449.02% | HC Wainwright公司 | →$7 | 重申 | →购买 |
| 02/14/2023 | 684.31% | EF Hutton | →$10 | 维护 | 买 |
| 01/05/2023 | 684.31% | EF Hutton | →$10 | 开始承保 | →购买 |
| 2022年11月14日 | 56.86% | 派珀·桑德勒 | $6→$2 | 维护 | 超重 |
| 2022年10月25日 | 449.02% | HC Wainwright公司 | $26→$7 | 维护 | 买 |
| 06/03/2022 | 1076.47% | 罗斯资本 | →$15 | 开始承保 | →购买 |
| 03/08/2021 | 1939.22% | BTIG | →$26 | 开始承保 | →购买 |
| 09/18/2020 | - | 威廉·布莱尔 | 开始承保 | →跑赢大盘 | |
| 07/23/2020 | 1939.22% | HC Wainwright公司 | $15→$26 | 维护 | 买 |
| 03/27/2020 | 1076.47% | HC Wainwright公司 | $25→$15 | 维护 | 买 |
| 2019年12月20日 | 1860.78% | HC Wainwright公司 | $31→$25 | 维护 | 买 |
| 2019年12月10日 | 2252.94% | 康托·菲茨杰拉德 | →$30 | 开始承保 | →超重 |
| 2019年11月20日 | 2331.37% | HC Wainwright公司 | $18→$31 | 重申 | →购买 |
| 2019年11月19日 | 2723.53% | 派珀·桑德勒 | $15→$36 | 维护 | 超重 |
| 2019年10月10日 | 1311.76% | HC Wainwright公司 | →$18 | 开始承保 | →购买 |
| 2019年05月13日 | 684.31% | 派珀·桑德勒 | →$10 | 开始承保 | →超重 |
| 2019年09月04日 | 998.04% | 韦德布什 | →$14 | 开始承保 | →跑赢大盘 |
What is the target price for Aravive (ARAV)?
Aravive(ARAV)的目标价是多少？
The latest price target for Aravive (NASDAQ: ARAV) was reported by BTIG on August 3, 2023. The analyst firm set a price target for $0.00 expecting ARAV to fall to within 12 months (a possible -100.00% downside). 20 analyst firms have reported ratings in the last year.
BTIG于2023年8月3日报道了Aravive(纳斯达克：ARIV)的最新目标价。这家分析公司将目标价定为0.00美元，预计ARAV值将在12个月内下降(跌幅可能为-100.00%)。去年，已有20家分析公司公布了评级。
What is the most recent analyst rating for Aravive (ARAV)?
分析师对Aravive(ARAV)的最新评级是多少？
The latest analyst rating for Aravive (NASDAQ: ARAV) was provided by BTIG, and Aravive downgraded their neutral rating.
纳斯达克(Sequoia Capital：ARIV)的最新分析师评级是由巴克莱国际提供的，Aravive下调了其中性评级。
When is the next analyst rating going to be posted or updated for Aravive (ARAV)?
Aravive(ARAV)的下一次分析师评级将于何时发布或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aravive, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aravive was filed on August 3, 2023 so you should expect the next rating to be made available sometime around August 3, 2024.
分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Aravive的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Aravive的上一次评级是在2023年8月3日提交的，所以你应该预计下一次评级将在2024年8月3日左右提供。
Is the Analyst Rating Aravive (ARAV) correct?
分析师对Aravive(ARAV)的评级正确吗？
While ratings are subjective and will change, the latest Aravive (ARAV) rating was a downgraded with a price target of $0.00 to $0.00. The current price Aravive (ARAV) is trading at is $1.27, which is out of the analyst's predicted range.
虽然评级是主观的，而且会发生变化，但最新的Aravive(ARAV)评级被下调，目标价在0.00美元至0.00美元之间。Aravive(ARAV)目前的交易价格为1.27美元，超出了分析师的预测区间。